Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Short Interest Update

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 36,100 shares, a decline of 80.5% from the February 28th total of 184,900 shares. Approximately 1.5% of the shares of the company are short sold. Based on an average daily trading volume, of 99,800 shares, the days-to-cover ratio is currently 0.4 days.

Creative Medical Technology Stock Performance

NASDAQ:CELZ opened at $2.21 on Thursday. The company has a 50-day moving average of $3.78 and a 200-day moving average of $3.24. Creative Medical Technology has a 52 week low of $1.92 and a 52 week high of $6.90. The company has a market capitalization of $3.86 million, a price-to-earnings ratio of -0.58 and a beta of 1.70.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Creative Medical Technology stock. Geode Capital Management LLC bought a new position in shares of Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 10,308 shares of the company’s stock, valued at approximately $25,000. Geode Capital Management LLC owned 0.59% of Creative Medical Technology at the end of the most recent reporting period. 1.42% of the stock is owned by institutional investors.

About Creative Medical Technology

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.